Genetics News and Research

Latest Genetics News and Research

Researchers use gene therapy to reduce the development of epileptic seizures

For the first time, researchers have inhibited the development of epilepsy after a brain insult in animals. By using gene therapy to modify signaling pathways in the brain, neurology researchers found that they could significantly reduce the development of epileptic seizures in rats.

8 Nov 2006

Inhibiting a particular cancer-causing gene improves radiation effectiveness

Inhibiting a particular cancer-causing gene can enhance the cell-killing effects of radiation, a team of radiation oncologists and cancer biologists at the Kimmel Cancer Center at Thomas Jefferson University in Philadelphia has found.

8 Nov 2006

Phase I clinical trial of experimental gene therapy to treat HIV shows encouraging results

The results of a Phase I clinical trial of an experimental gene therapy aimed at treating HIV indicate that the therapy is safe and effective and also might sustain viral loads, according to a study published on Monday in the online edition of the Proceedings of the National Academy of Sciences, the AP/Washington Post reports.

8 Nov 2006

UIC study evaluates two medications for ADHD

University of Illinois at Chicago researchers are comparing two drugs commonly used to treat attention deficit hyperactivity disorder to determine if genetic factors predict which children will respond to either or both drugs.

7 Nov 2006

Jet lag could be a killer

Researchers in the U.S. have found that jet lag or rotating shift work shortens the lifespan in mice and they say it raises concerns for humans affected by time disruption.

7 Nov 2006

Environment the culprit in women's higher risk of MS

Researchers in the UK are suggesting that there is an environmental link to the rising number of women being diagnosed with multiple sclerosis (MS) in Canada.

1 Nov 2006

Potential for first diagnostic DNA test to guide antidepressant treatment

Treatment of depression is difficult for both patients and for psychiatrists. While there are numerous drugs available that work, finding the right one -- or right combination -- is, at times, a matter of trial and error.

31 Oct 2006

Effective test for screening Huntington's disease drugs

A test using cultured cells provides an effective way to screen drugs against Huntington's disease and shows that two compounds - memantine and riluzole - are most effective at keeping cells alive under conditions that mimic the disorder, UT Southwestern Medical Center researchers report.

30 Oct 2006

First research, treatment clinic for inflammatory breast cancer to open at University of Texas

The University of Texas MD Anderson Cancer Center in Houston on Wednesday is scheduled to open the "first clinic in the world" dedicated to the research and treatment of inflammatory breast cancer, the Houston Chronicle reports.

24 Oct 2006

ODC genetic variation impacts aspirin's effectiveness in preventing colon cancer

Dartmouth researchers are among a team of doctors that have learned more about how people may or may not benefit from taking aspirin in the effort to curb colon cancer.

24 Oct 2006

Scientists explain how transport proteins can move in cells without bumping into or sticking to anything

Scientists from the Max Planck Institute for Molecular Cell Biology and Genetics (MPI-CBG) in Dresden, along with a colleague from the University of Florida in the United States, have been carrying out research into how transport proteins can move in cells without bumping into or sticking to anything.

24 Oct 2006

Further European investment in genomics

The Economic and Social Research Council (ESRC) has announced continued funding, from 2007 to 2012, for its three research centres, CESAGen, EGENIS and INNOGEN, that, along with the ESRC Genomics Policy and Research Forum, make up the ESRC Genomics Network.

23 Oct 2006

Period 2 gene - key component of the circadian time-keeping system

By investigating how animals can predict the timing of food availability, researchers have identified the first gene critical for anticipation of mealtime. This gene, called Period 2, is a key component of the circadian time-keeping system.

23 Oct 2006

Common gene variant increases risk of developing diabetes

Carrying two copies of a common variant of a particular gene doubles your chances of developing diabetes and puts you in a similar risk category to being clinically obese, according to a collaborative study led by UCL (University College London) researchers.

23 Oct 2006

Eye color reflects a simple, predictable and reliable genetic pattern of inheritance

Before you request a paternity test, spend a few minutes looking at your child's eye color. It may just give you the answer you're looking for.

23 Oct 2006

Genomic test decides which drug is best for cancers

Scientists at Duke University, North Carolina have developed a panel of tests which are able to analyze a cancerous tumor and then decide which chemotherapy will most efficiently attack the cancer.

23 Oct 2006

Otoferlin, defective in a human deafness form, is essential for exocytosis at the auditory ribbon synapse

By studying a gene earlier linked to deafness in humans, researchers now have new insight into the molecular process by which components of the inner ear send messages to the brain.

20 Oct 2006

Scientists identify gene called HTRA1 that contributes to a major risk of Age Related Macular Degeneration

Researchers at the John A. Moran Eye Center at the University of Utah have identified a gene called HTRA1 that contributes to a major risk of Age Related Macular Degeneration (AMD), the most common cause of irreversible vision loss in the developed world.

20 Oct 2006

Scientists discover how brain turns on system designed to protect nerve cells from toxic "free radicals"

Scientists at Dana-Farber Cancer Institute report they have found how the brain turns on a system designed to protect its nerve cells from toxic "free radicals," a waste product of cell metabolism that has been implicated in some degenerative brain diseases, heart attacks, strokes, cancer, and aging.

20 Oct 2006

PGC-1 alpha implicated in Huntington's disease neurodegeneration

A metabolic disorder underlies the brain effects found in those with Huntington's disease, researchers report in an advance article publishing online October 19, 2006. The article will appear in the November 2006 issue of the journal Cell Metabolism, published by Cell Press.

20 Oct 2006

Genetics News and Research

Latest Genetics News and Research

Researchers use gene therapy to reduce the development of epileptic seizures

Inhibiting a particular cancer-causing gene improves radiation effectiveness

Phase I clinical trial of experimental gene therapy to treat HIV shows encouraging results

UIC study evaluates two medications for ADHD

Jet lag could be a killer

Environment the culprit in women's higher risk of MS

Potential for first diagnostic DNA test to guide antidepressant treatment

Effective test for screening Huntington's disease drugs

First research, treatment clinic for inflammatory breast cancer to open at University of Texas

ODC genetic variation impacts aspirin's effectiveness in preventing colon cancer

Scientists explain how transport proteins can move in cells without bumping into or sticking to anything

Further European investment in genomics

Period 2 gene - key component of the circadian time-keeping system

Common gene variant increases risk of developing diabetes

Eye color reflects a simple, predictable and reliable genetic pattern of inheritance

Genomic test decides which drug is best for cancers

Otoferlin, defective in a human deafness form, is essential for exocytosis at the auditory ribbon synapse

Scientists identify gene called HTRA1 that contributes to a major risk of Age Related Macular Degeneration

Scientists discover how brain turns on system designed to protect nerve cells from toxic "free radicals"

PGC-1 alpha implicated in Huntington's disease neurodegeneration

Genetics & Genomics - Second Edition eBook

Expanding research and clinical options for children with cancer

Examining how pain could play a direct protective role in the gut

From Puberty to Menopause: Clue’s CEO, Audrey Tsang on the Power of Femtech